A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 17,018 shares of FLGT stock, worth $319,257. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,018
Holding current value
$319,257
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$19.6 - $25.06 $333,552 - $426,471
17,018 New
17,018 $369,000
Q1 2022

May 16, 2022

SELL
$49.85 - $96.11 $283,197 - $546,000
-5,681 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$77.3 - $105.0 $439,141 - $596,505
5,681 New
5,681 $571,000
Q1 2021

May 17, 2021

SELL
$59.3 - $183.85 $597,091 - $1.85 Million
-10,069 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$31.01 - $52.1 $312,239 - $524,594
10,069 New
10,069 $525,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $568M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.